GuidesMedication guide
Semaglutide, explained properly
What it is, how it actually works, what the trials showed, what the first months feel like, and the safety facts your physician weighs before prescribing it.
What semaglutide is
Semaglutide is a GLP-1 receptor agonist — a molecule built to mimic a hormone your gut already releases after you eat. That hormone, GLP-1, tells your brain you’re satisfied, slows how quickly your stomach empties, and helps regulate blood sugar. Semaglutide sends the same signal, but steadily, all week, from one injection.
The molecule has been prescribed since 2017, first for type 2 diabetes and later for weight management, and is among the most-studied medications of the last decade. On Conduit, semaglutide is compounded for you by a licensed US pharmacy against your physician’s individual prescription.
How it actually works
Most people expect an appetite suppressant. What they describe instead is quieter: the constant background negotiation with food — what to eat next, whether to finish the plate, the 9pm pull toward the kitchen — turns down. Members call it the food noise going quiet.
Mechanically, three things are happening: your brain receives a satiety signal earlier and holds it longer; your stomach empties more slowly, so meals keep you full for hours more than they did; and your blood sugar swings flatten, which removes the crash-and-crave cycle. Weight loss follows from eating meaningfully less without the willpower fight — the medication changes the terms of the negotiation rather than asking you to win it.
What the trials showed
In the 68-week STEP trial program, adults taking weekly semaglutide alongside lifestyle support lost an average of around 15% of their body weight — the mean, not the best case. About a third of participants lost 20% or more; some lost less than 10%. Response is genuinely individual, which is exactly why the dose is physician-managed rather than fixed.
Two honest footnotes. The trials paired the medication with nutrition and activity changes — it was studied as part of a program, and that is how your physician will treat it. And when the medication stops, appetite returns; maintaining the result is a real phase of treatment, not an afterthought. Both of these are covered in the journey guide.
The dosing journey — the standard schedule
Semaglutide is never started at full strength. The published prescribing schedule steps up roughly every four weeks as your body adapts — starting low is what keeps the side effects manageable. The numbers below are the standard, public schedule, shown so you know the shape of the road. Your physician sets your actual pace from your monthly check-ins, may hold you at any step for as long as it serves you, and many members maintain below the maximum.
| Weeks | Weekly dose & what’s happening |
|---|---|
| Weeks 1–4 | 0.25 mg — the adaptation dose. The goal is tolerance, not weight loss; some people feel the appetite change immediately, others not yet. Mild nausea in week one is common and usually passes. |
| Weeks 5–8 | 0.5 mg — the first working step. The food-noise effect becomes unmistakable for most people around here. |
| Weeks 9–16 | 1.0 mg, then 1.7 mg as tolerated. Steady loss is typically established in this stretch; step-ups are where side effects briefly revisit. |
| Week 17+ | 2.4 mg — the full maintenance dose, if you need it. Plenty of members hold at 1.0 or 1.7 because that’s where effect and comfort meet. More is not better; the right dose is the one you feel good at. |
One thing that never changes across this journey on Conduit: your price. You pay the same at 0.25 mg and at 2.4 mg.
Side effects, honestly
Most side effects are gastrointestinal, front-loaded into the first weeks and dose increases, and fade as your body adapts. The common ones — the same list your monthly check-in asks about — are nausea, constipation, diarrhea, reflux, bloating, fatigue, and occasional dizziness.
Most of it is manageable with mechanics rather than medicine: smaller meals, eaten slower, stopping at satisfied instead of full; steady hydration; less alcohol and less fried food in titration weeks. If a side effect is more than a nuisance, that is exactly what the check-in is for — your physician can slow the titration or hold your dose, and usually that resolves it. You never have to tough it out silently, and you shouldn’t.
Stop and seek care if
A short list of symptoms means stop the medication and get medical care now — not a portal message, actual care:
- Severe abdominal pain that doesn’t pass, especially radiating to your back (possible pancreatitis)
- Vomiting that won’t stop, or signs of serious dehydration
- Yellowing of skin or eyes (jaundice)
- Swelling of face or throat, trouble breathing (allergic reaction)
The serious risks, plainly
Rare risks deserve plain language more than common ones do, so here is the full set — the same facts on the medication class’s prescribing information, without the legal typeface:
- Thyroid — in rodent studies, medications in this class caused a type of thyroid tumor (C-cell); whether that translates to humans is unknown. Out of caution it is never prescribed to anyone with a personal or family history of medullary thyroid carcinoma or MEN2. A new neck lump, hoarseness, or trouble swallowing should go to a doctor regardless.
- Pancreatitis — rare but serious inflammation of the pancreas. It is the reason “severe abdominal pain radiating to your back” sits on the stop-and-seek-care list, and why a history of pancreatitis changes the prescribing conversation.
- Gallbladder — losing weight quickly raises gallstone risk by itself, and trials saw more gallbladder events on medication than placebo. New pain under the right ribs, especially after meals, deserves care.
- Kidneys — the real mechanism is dehydration: vomiting or diarrhea you don’t replace can strain the kidneys. This is why hydration in the side-effect section is medical advice, not a wellness garnish.
- Low blood sugar — mainly a risk when combined with insulin or sulfonylureas. It is why the intake asks precisely what diabetes medications you take.
- Mood — prescribing guidance for weight-management medications advises watching for new or worsening depression or thoughts of self-harm. It is uncommon, your check-ins ask, and anything in this territory belongs with your physician immediately.
- Eyes — for members with diabetes, rapidly improving blood sugar can temporarily worsen diabetic retinopathy. If you have diabetic eye disease, your physician needs to know.
- Pregnancy — not used while pregnant or breastfeeding, and if you are planning a pregnancy, the medication is stopped about two months in advance. That timeline is planned with your physician, not discovered later.
Who it isn’t for
Some of the intake questions exist because semaglutide is genuinely off the table for certain histories: a personal or family history of medullary thyroid carcinoma or MEN2, pregnancy or breastfeeding, and current eating-disorder treatment are absolute stops. A history of pancreatitis, gallbladder disease, severe reflux or gastroparesis, or insulin-dependent diabetes doesn’t always rule it out — but it changes the conversation, and your physician may decline or coordinate with your existing care.
This is the honest reason “a doctor reviews every protocol” isn’t marketing language. Sometimes the right prescription is no.
Questions members actually ask
Do I have to inject on the same day every week?
It’s once weekly, any time of day, with or without food. The day can move when life demands it — the published rule is simply to keep at least 48 hours between doses — and if you’re ever unsure how to resume, ask through the portal before improvising.
Is compounded semaglutide the same as the brand-name pen?
It is the same active molecule, prepared for you by a licensed US compounding pharmacy against your physician’s prescription rather than sold as the FDA-approved branded product. Your physician decides whether it’s appropriate for you, and every batch ships from a licensed pharmacy with the pen, needles, and cold-chain handling included.
How fast will I lose weight?
Slower at first than you’d hope, then steadier than you’d expect. The first month is a low, adaptation dose — meaningful loss typically builds over months two to six. In trials, the ~15% average took over a year. Anyone promising faster is selling something other than medicine.
What happens to my appetite if I stop?
It comes back — the trials are clear about that, and weight regain is common after stopping without a maintenance plan. Treat stopping as a decision to make with your physician, not a cliff to walk off.
Can I drink alcohol?
There’s no absolute prohibition, but most people find alcohol hits harder and sits worse, especially during titration — and it works against the appetite mechanics you’re paying for. During dose increases, less is genuinely better.
Will my dose — and my price — keep going up?
Your dose steps up until you and your physician find the level that works, then holds. Your price never moves with your dose on Conduit — one flat rate at every strength, which is not how most of this market prices.
Important Safety Information for Compounded Semaglutide →
This guide is educational and is not medical advice. It restates the Conduit clinical protocol in plain language; your physician’s individual guidance always comes first. If you are experiencing a medical emergency, call 911.